对滤泡性淋巴瘤转化的更新认识
本文综述了滤泡性淋巴瘤(FL)转化为侵袭性淋巴瘤(tFL)的生物学基础、诊断与临床管理。tFL以额外遗传学改变、新信号通路上调及源自共享FL起始突变的祖克隆为特征,预后较差,尤其对既往接受FL定向治疗者。预测转化风险是研究重点,记忆样B细胞表型与肿瘤-免疫相互作用受关注,新型免疫治疗正在改善结局但仍需更多临床数据。
要点
- tFL源自共享FL起始突变的祖克隆,伴额外遗传学改变与新信号通路上调。
- 既往接受FL定向治疗的患者转化后结局尤其差。
- 记忆样B细胞表型与转化风险相关,肿瘤-免疫相互作用在转化出现时起关键作用。
核心结论
- 本综述总结了tFL近期科学与临床研究,提供其生物学基础、诊断和临床管理的更新认识,并提出未来研究计划以提高tFL生物学认识并改善患者结局。
研究设计与样本
- 综述,检索范围未具体报告。
主要发现
- 与FL相比,tFL以众多额外遗传学改变、新信号通路上调为特征,并源自共享FL起始突变的祖克隆。
- 预测tFL风险仍是疾病研究的高度优先领域,近期工作强调记忆样B细胞表型与转化风险相关,并提示肿瘤-免疫相互作用在转化出现时起关键作用。
- 机制研究为遗传驱动因素在决定恶性B细胞表型或减少微环境依赖中的作用提供见解。
- 以新型免疫治疗为标志的治疗格局变化正在改善患者结局,但仍亟需更多tFL临床结局数据。
局限性
- 原文指出仍需大量tFL临床结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although most patients with follicular lymphoma (FL) follow an indolent disease course, some patients experience a critical inflection point when FL transforms into an aggressive lymphoma. Historically, FL transformation is marked by poor outcomes, particularly for patients with previous FL-directed treatment. Compared with FL, transformed FL (tFL) is marked by numerous additional genetic changes, upregulates novel signaling pathways, and arises from an ancestral FL clone with shared FL-initiating mutations. Prediction of tFL risk remains a high-priority area of disease research, with recent work highlighting memory-like B-cell phenotypes associated with transformation risk and implicating critical tumor-immune interactions at transformation emergence. Mechanistic studies provide insight into the role of genetic drivers in determining malignant B-cell phenotypes or reducing microenvironmental dependencies. In parallel, a shifting therapeutic landscape marked by novel immune-based therapeutics is improving outcomes for patients, yet further clinical outcome data in tFL are greatly needed. This review summarizes recent scientific and clinical studies in tFL and provides an updated understanding of the biological basis, diagnosis, and clinical management of tFL. We conclude with a proposed plan of future research aimed at the goal of increasing tFL biologic knowledge and improving outcomes for patients with tFL.
引用
- Parry EM, Okosun J. An updated understanding of follicular lymphoma transformation. Blood. 2025. PMID: 40373273. doi:10.1182/blood.2024026016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。